NEWTON-2 cisternal (Nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage): A phase 2, multicenter, randomized, open-label safety study of intracisternal EG-1962 in aneurysmal subarachnoid hemorrhage

R. Loch Macdonald, Daniel Hänggi, Nerissa U. Ko, Tim E. Darsaut, Andrew P. Carlson, George K. Wong, Nima Etminan, Stephan A. Mayer, E. Francois Aldrich, Michael N. Diringer, David Ng, Poul Strange, Thomas Bleck, Robert Grubb, Jose I. Suarez

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'NEWTON-2 cisternal (Nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage): A phase 2, multicenter, randomized, open-label safety study of intracisternal EG-1962 in aneurysmal subarachnoid hemorrhage'. Together they form a unique fingerprint.

Medicine & Life Sciences